Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy

NCT03578185 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03578185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03578185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
April 11, 2018
Completion date
December 31, 2030
Enrollment
2,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer